173 results
8-K
EX-10.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
17 Oct 23
Entry into a Material Definitive Agreement
7:24pm
effect to the addbacks set forth in this clause (iii) and clauses (iv) and (xiii) below),
(iv) one-time non-recurring severance, retention … owned or being purchased by such Person (including indebtedness arising under conditional sales or other title retention agreements), whether
8-K
EX-10.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
4 Nov 22
Unaudited Pro Forma Condensed Consolidated Financial Statements
4:08pm
in Section 5.4, (b) the Tax Materials or (c) the Tax-Free Status of the Transactions.
ARTICLE VIII
RETENTION OF RECORDS; ACCESS
8.1 Retention
S-3ASR
EX-1.2
ked sj6ylk5z9vdxooxl
30 Sep 22
Automatic shelf registration
4:17pm
S-3ASR
EX-4.3
eclxcuw
30 Sep 22
Automatic shelf registration
4:17pm
425
if3tm4 cp
24 Mar 22
Business combination disclosure
9:09am
8-K
EX-2.2
tvl3fk s3f4n
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-10.1
92hb23o
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-2.1
2a6zgqj0sejskcu1yppm
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
vujble8t07j
3 Dec 20
Other Events
12:00am